Results 31 to 40 of about 48,911 (308)

Pattern of asthma medication use among children from a large urban center in Brazil. [PDF]

open access: yes, 2011
PURPOSE: Despite the advances in asthma therapeutics, there are few data on the use and determinants of anti-asthmatic drugs in the general population of children.
Barreto, Mauricio L   +13 more
core   +1 more source

The WISDOM of inhaled corticosteroids in COPD [PDF]

open access: yesThorax, 2014
Current national and international guidelines recommend the use of inhaled corticosteroids (ICS) in addition to long-acting bronchodilators in people with more severe COPD to reduce the risk of exacerbations. Opinions on the benefits and role of ICS in COPD have changed considerably over the last 25 years.
Halpin, DMG, Quint, JK
openaire   +3 more sources

Idiopathic intracranial hypertension as a presenting sign of adrenal insufficiency

open access: yesSAGE Open Medical Case Reports, 2018
Idiopathic intracranial hypertension is a diagnosis of exclusion defined by elevated intracranial pressure without mass lesions or hydrocephalus.
Sandra Shenouda   +3 more
doaj   +1 more source

Withdrawal of inhaled corticosteroids in individuals with COPD - a systematic review and comment on trial methodology

open access: yes, 2011
Inhaled corticosteroids (ICS) reduce COPD exacerbation frequency and slow decline in health related quality of life but have little effect on lung function, do not reduce mortality, and increase the risk of pneumonia. We systematically reviewed trials in
Eldridge Sandra M   +8 more
core   +1 more source

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy? [PDF]

open access: yes, 2018
Donald P Tashkin,1 Charlie Strange2 1Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA; 2Department of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC, USA
Strange, Charlie   +3 more
core   +1 more source

A simple prediction tool for inhaled corticosteroid response in asthmatic children

open access: yesBMC Pulmonary Medicine, 2017
Background Inhaled corticosteroids are recommended as the first-line controller medication for childhood asthma owing to their multiple clinical benefits.
Yi-Fan Wu   +5 more
doaj   +1 more source

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma

open access: yes, 2011
Asthma patients who continue to experience symptoms despite being on regular inhaled corticosteroids (ICS) represent a management challenge. Long-acting beta2-agonists (LABA) or anti-leukotrienes (LTRA) are two treatment options that could be considered ...
Christopher J Cates   +5 more
core   +1 more source

Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives

open access: yesAdvanced Science, EarlyView.
This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård   +19 more
wiley   +1 more source

Inhaled corticosteroids for abnormal pulmonary function in children with a history of Chronic Lung Disease of Infancy: study protocol [ISRCTN55153521]

open access: yesBMC Pulmonary Medicine, 2005
Background There is considerable evidence from the literature that children with chronic lung disease of infancy (CLD) have abnormal pulmonary function in childhood and this could have an impact on their life quality and overall health.
Sauve Reginald   +4 more
doaj   +1 more source

Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

open access: yesBMC Pulmonary Medicine, 2023
Background The fracture risk of patients with chronic obstructive pulmonary disease (COPD) treated with inhaled corticosteroids is controversial. And some large-scale randomized controlled trials have not solved this problem.
Shisheng Peng   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy